Table Graph
      published meta-analysis   sensitivity analysis   studies

Indomethacin in COVID 19 hospitalized - Summary of results

OutcomeTE95% CInkI2ROBPub. bias clinical deteriorationdetailed resultsRavichandran, 2021 0.02 [0.00; 0.36] 0.02[0.00; 0.36]Ravichandran, 202110%210NAnot evaluable viral clearance detailed resultsRavichandran, 2021 1.71 [0.80; 3.64] 1.71[0.80; 3.64]Ravichandran, 202110%122NAnot evaluable viral clearance by day 7detailed resultsRavichandran, 2021 1.71 [0.80; 3.64] 1.71[0.80; 3.64]Ravichandran, 202110%122NAnot evaluable adverse eventsdetailed resultsRavichandran, 2021 1.04 [0.02; 52.86] 1.04[0.02; 52.86]Ravichandran, 202110%210NAnot evaluable0.05.01.0relative treatment effectwww.metaEvidence.org2024-04-27 20:19 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 95,94,90,91 - treatments: 836 - roots T: 290

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons